Fennec Pharmaceuticals Inc (FENC)
9.57
-0.13
(-1.34%)
USD |
NASDAQ |
Apr 18, 16:00
9.57
0.00 (0.00%)
After-Hours: 20:00
Fennec Pharmaceuticals Cash from Investing (TTM)
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
September 30, 2014 | 0.00 |
June 30, 2014 | 0.00 |
March 31, 2014 | 0.00 |
December 31, 2013 | 0.00 |
September 30, 2013 | 0.00 |
June 30, 2013 | 0.00 |
March 31, 2013 | 0.00 |
December 31, 2012 | 0.00 |
September 30, 2012 | 0.00 |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
December 31, 2011 | 0.00 |
September 30, 2011 | 0.00 |
June 30, 2011 | 0.00 |
March 31, 2011 | 0.00 |
December 31, 2010 | 0.00 |
September 30, 2010 | 0.00 |
June 30, 2010 | 0.00 |
March 31, 2010 | 0.024M |
December 31, 2009 | |
September 30, 2009 | |
June 30, 2009 | |
March 31, 2009 | |
December 31, 2008 | -0.015M |
September 30, 2008 | 5.039M |
Date | Value |
---|---|
June 30, 2008 | -0.054M |
March 31, 2008 | -0.09M |
December 31, 2007 | -0.075M |
September 30, 2007 | -5.129M |
June 30, 2007 | -0.036M |
March 31, 2007 | 0.391M |
December 31, 2006 | 1.17M |
September 30, 2006 | 3.400M |
June 30, 2006 | -0.052M |
March 31, 2006 | -0.457M |
December 31, 2005 | -1.255M |
September 30, 2005 | -3.537M |
June 30, 2005 | -7.096M |
March 31, 2005 | -7.117M |
September 30, 2004 | -7.104M |
June 30, 2004 | -7.071M |
March 31, 2004 | 0.3622M |
December 31, 2003 | 0.6945M |
September 30, 2003 | 5.138M |
June 30, 2003 | 5.112M |
March 31, 2003 | -0.8789M |
December 31, 2002 | -1.264M |
September 30, 2002 | -5.797M |
June 30, 2002 | -5.797M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
Pfizer Inc | -32.28B |
OptiNose Inc | -0.328M |
NovaBay Pharmaceuticals Inc | -0.019M |
Palatin Technologies Inc | 9.293M |
iBio Inc | 8.285M |